Ameritas Investment Partners, Inc. Rain Therapeutics Inc. Transaction History

Ameritas Investment Partners, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$1.09 - $9.93 $1,529 - $13,931	1,403 New	1,403 $1,000
Q2 2022 Aug 12, 2022	SELL	$2.21 - $5.56 $2,718 - $6,838	-1,230 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$11.91 - $17.0 $7,717 - $11,016	648 Added 111.34%	1,230 $16,000
Q2 2021 Aug 06, 2021	BUY	$15.08 - $20.3 $8,776 - $11,814	582 New	582 $9,000

122K

Ticker RAIN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,837,400
Description
Rain Therapeutics Inc., a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States. Its lead product candidate is milademetan, a small molecule oral inhibitor of mouse double minute 2, which is oncogenic in various cancers. The company is also developing milademetan which is in...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.